Renal
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
0
studies recruiting now
as of 7 Sept 2026
0
studies registered in total
as of 7 Sept 2026
0
countries with a recruiting site
as of 7 Sept 2026
None
recruiting study posted to date
among recruiting studies
Recruiting trials
No registered studies found for Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.
Keep watching
Get an email when a new Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (CYP21A2).
Treatments being studied
2 approved treatments and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).